Data / Drug companies / Sina Health Inc
Sina Health Inc: 7 products in the FDA NDC directory, labeler code 70385
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sina Health Inc (labeler code 70385) lists 7 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 6 prescription drugs, 1 over the counter drugs. Its main marketing category is authorized generics (NDA). The newest product started marketing on July 20, 2020.
The request: Watch Sina Health Inc (FDA labeler code 70385): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 70385
- Products in commercial distribution
- 7
- Packages
- 7
- Finished drugs by generic name
- 5
- Prescription products
- 6
- Over the counter products
- 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- April 1, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Authorized generics (NDA) | 4 | 57.1% |
| Over the counter monograph drugs | 1 | 14.3% |
| New drug applications (NDA) | 1 | 14.3% |
| Generic drugs (ANDA) | 1 | 14.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 6 | 85.7% |
| Over the counter drugs | 1 | 14.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Epinephrine 0.15 pediatrics | 2 | 1 |
| Epinephrine 0.3 adults | 2 | 1 |
| Aspirin | 1 | 134 |
| Epinephrine | 1 | 32 |
| Naloxone hydrochloride | 1 | 40 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 5 | 71.4% |
| Tablet, film coated | 1 | 14.3% |
| Injection, solution | 1 | 14.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Catecholamine | 5 |
| alpha-Adrenergic Agonist | 5 |
| beta-Adrenergic Agonist | 5 |
| Nonsteroidal Anti-inflammatory Drug | 1 |
| Platelet Aggregation Inhibitor | 1 |
| Opioid Antagonist | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Aspirin Packs | 70385-2006 | Tablet, film coated | Over the counter monograph drugs | July 20, 2020 |
| Naloxone Hydrochloride | 70385-2033 | Injection, solution | Generic drugs (ANDA) | August 8, 2017 |
| Epinephrine 0.15 Pediatrics | 70385-2020 | Injection | Authorized generics (NDA) | December 15, 2016 |
| Epinephrine 0.3 Adults | 70385-2019 | Injection | Authorized generics (NDA) | December 15, 2016 |
| Adrenalin Vials | 70385-2024 | Injection | New drug applications (NDA) | July 1, 2013 |
| Epinephrine Pediatrics | 70385-2038 | Injection | Authorized generics (NDA) | April 1, 2010 |
| Epinephrine 0.3 Adults | 70385-2022 | Injection | Authorized generics (NDA) | April 1, 2010 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.